Vincent Perrone | executive |
Elizabeth Barrett | executive |
Mark Schoenberg | executive |
Jeffrey Bova | executive |
Dong Kim | executive |
Tara Bancroft | analyst |
Raghuram Selvaraju | analyst |
Matthew Kaplan | analyst |
Leland Gershell | analyst |
Good morning, ladies and gentlemen. Thank you for standing by. Welcome to the UroGen Pharma First Quarter 2024 Earnings Call. Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your first speaker today, Vincent Perrone, Head of Investor Relations.